# Effect of Oral L-arginine 3.32 g a Day on Oxidative Stress Influencing Beta Cell Function and Insulin Resistance.

> **NCT06686069** · NA · NOT_YET_RECRUITING · sponsor: **Federico II University** · enrollment: 42 (estimated)

## Conditions studied

- Diabetes
- Pre-diabetes
- Metabolic Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** bioarginina zero
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT06686069
- **Lead sponsor:** Federico II University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-18
- **Primary completion:** 2025-11-18
- **Final completion:** 2025-12-30
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2024-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06686069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06686069, "Effect of Oral L-arginine 3.32 g a Day on Oxidative Stress Influencing Beta Cell Function and Insulin Resistance.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06686069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*